Diagnosing Dx

Est. audience

100

Apple rating

5 from 2

Cadence

Weekly

Latest

2026-10-27

By

Elevra Consulting

Based on

12 recent episodes

• Covers: Scientific innovation, commercialization strategies, payer challenges, strategic partnerships, and emerging technology in medical diagnostics.
• For: Founders, executives, and researchers in the diagnostics and omics industries.
• Best for: Diagnostics company founders seeking insights on commercial growth, scaling, and market navigation.
• Skip if: General consumers looking for personal healthcare advice or medical self-diagnosis tips.

Start with

• Can Strategic Partnerships Save Diagnostics Innovation? Robert Carlson: Explains why early-stage diagnostics companies should leverage strategic partnerships for innovation.
• Will Payer-Dependent Diagnostics Companies Get Left Behind? Marty Keiser, Founder at IVBH / Mammogen: Discusses business models and payer dynamics in molecular diagnostics and early disease detection.
• What Can Diagnostics Founders Learn From Two Successful Exits? Andrew Miller: Shares lessons on building, scaling, and selling rapid molecular diagnostics companies.

Visit

Summarised by AI from 12 recent episodes. Audience estimate and Apple rating from Podscan, checked 2026-11-03; treat the estimate as a guide and ask the show for its own numbers. Prices are not included. Report a mistake.